Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
Authors:
Open Access
- 27 June 2023
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 16 (1) , 1-10
Abstract
Background: Mucinous epithelial ovarian cancer (mEOC) is a relatively uncommon subtype of ovarian cancer with special prognostic features, but there is insufficient research in this area. This study aimed to develop a nomogram for the cancer-specific survival (CSS) of mEOC based on Surveillance, Epidemiology, and End Results (SEER) database and externally validate it in National Union of Real World Gynecological Oncology Research and Patient Management (NUWA) platform from China. Methods: Patients screened from SEER database were allocated into training and internal validation cohort in a ratio of 7: 3, with those from NUWA platform as an external validation cohort. Significant factors selected by Cox proportional hazard regression were applied to establish a nomogram for 3-year and 5-year CSS. The performance of nomogram was assessed by concordance index, calibration curves and Kaplan-Meier (K-M) curves. Results: The training cohort (n = 572) and internal validation cohort (n = 246) were filtered out from SEER database. The external validation cohort contained 186 patients. Baseline age, tumor stage, histopathological grade, lymph node metastasis and residual disease after primary surgery were significant risk factors (p < 0.05) and were included to develop the nomogram. The C-index of nomogram in training, internal validation and external validation cohort were 0.869 (95% confidence interval [CI], 0.838-0.900), 0.839 (95% CI, 0.787–0.891) and 0.800 (95% CI, 0.738–0.862), respectively. The calibration curves of 3-year and 5-year CSS in each cohort showed favorable agreement between prediction and observation. K-M curves of different risk groups displayed great discrimination. Conclusion: The discrimination and goodness of fit of the nomogram indicated its satisfactory predictive value for the CSS of mEOC in SEER database and external validation in China, which implies its potential application in different populations.Keywords
Funding Information
- National Key Technology Research and Development Programme of China (2022YFC2704200)
- National Natural Science Foundation of China (81772787)
- Major Project of Chinese Society of Medical Education (20A0769)
- Beijing Xisike Clinical Oncology Research Foundation (Y-2019AZZD-0359)
This publication has 32 references indexed in Scilit:
- Mucinous ovarian cancer: A therapeutic reviewCritical Reviews in Oncology/Hematology, 2016
- Mucinous epithelial ovarian carcinomaAnnals of Oncology, 2016
- Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian MetastasesInternational Journal of Gynecological Cancer, 2015
- Nomograms in oncology: more than meets the eyeThe Lancet Oncology, 2015
- Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United StatesGynecologic Oncology, 2015
- Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian CancerAnnals of Surgical Oncology, 2012
- Comparability of stage data in cancer registries in six countries: Lessons from the International Cancer Benchmarking PartnershipInternational Journal of Cancer, 2012
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trialsCancer, 2009
- How To Build and Interpret a Nomogram for Cancer PrognosisJournal of Clinical Oncology, 2008
- X-TileClinical Cancer Research, 2004